Akrivisbio Inc. announces the introduction of a new line of metabolic assay kits

November 02, 2023 06:22 PM AEDT | By EIN Presswire

Google News:

Akrivisbio Inc. announces the introduction of a new line of metabolic assay kits — Image source: Kalkine Media

Recent News

SHL and XRO: Two Noteworthy Players Among ASX 100 Companies

Marmota Kicks Off First-Ever Drilling Program at Greenewood Gold Prosp...

Buru Energy Secures Key Licensing Extension, Paving Way to 2027 Gas Pr...

Gold Miners Anchor ASX as Global Tariff Moves Fuel Uncertainty

FREMONT, CALIFORNIA, UNITED STATES, November 2, 2023 /EINPresswire.com/ -- AkrivisBio is introducing a new line of metabolic assay kits covering the most popular targets sought by researchers. With the new line of assays including assays for metabolic intermediates, as well as cell proliferation and toxicity assays, users can quantify more than 200 of the most common metabolic intermediates, enzymes, cofactors and ions with increased precision, greater ease, and lower cost.

“One of our founding principles at AkrivisBio is to provide robust metabolic assays, which provide increased precision with a minimum amount of user effort as economically as possible,” said Nick Chacos, CEO of AkrivisBio. “Organizations are increasingly looking for reliable, reproducible, ready-to-use assays rather than developing them in-house so they can spend their time on the more important aspects of their research". Our assays are instrumental in biochemical research looking for solutions to cancer, diabetes, obesity, neurodegenerative disease, and other fields.

Based in the beautiful Bay area of Northern California, AkrivisBio is focused on improving the user experience with enzyme-based metabolic assays. Learn more at www.akrivisbio.com.

shyamali mandal
AkrivisBio Inc.
+1 309-857-5349
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.